IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.95% | 11.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.29% | 4.63% | |||
| Operating Income | 6.29% | -4.63% | |||
| Income Before Tax | 6.07% | -2.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.07% | -2.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.07% | -2.99% | |||
| EBIT | 6.29% | -4.63% | |||
| EBITDA | 6.00% | -5.23% | |||
| EPS Basic | 6.08% | 62.42% | |||
| Normalized Basic EPS | 6.06% | 62.43% | |||
| EPS Diluted | 6.08% | 62.42% | |||
| Normalized Diluted EPS | 6.06% | 62.43% | |||
| Average Basic Shares Outstanding | 0.00% | 174.13% | |||
| Average Diluted Shares Outstanding | 0.00% | 174.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||